Tulane Virus as a Human Norovirus Surrogate - Xi Jiang, Ph. D. Cincinnati Children s Hospital Medical Center University of Cincinnati College of ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Tulane Virus as a Human Norovirus Surrogate Xi Jiang, Ph. D. Cincinnati Children s Hospital Medical Center University of Cincinnati College of Medicine Cincinnati, OH
Tulane virus • Isolated in stools of rhesus macaques captured in Tulane Primate Center • Proposed to be a new genus Recovirus • Genetically closest to human NoVs than to other CV genera • Replicate in monkey kidney cells (LLCMK-2) • Recognizing human HBGA (B antigen) like human NoVs • A reverse genetic system has been developed • Experimental challenge of Rhesus Macaques with TV has resulted in infection and illness in 2 of 3 animals (Sestak et al., PLoS One, 2012) • Cryo-EM structure of the prototype TV has been resolved • With the funding of this USDA NIFA project, a number of important reagents have been generated: • Antibodies against individual structural and non-structural proteins • Monoclonal antibodies against TV • Adaptation of TV into several monkey kidney cells Farkas et al., 2008; Wei, et al., 2008; and Yu et al., submitted
Comparison of TV with other HuNoV surrogates (MNV and FCV) • Thermal inactivation • Stability to extreme pH • Disinfection, alcohol, bleach, UV • Long-term persistence in fecal matrix in environmental conditions • Organic solvent stability • Real-time RT-PCR and plaque assay • Duplicate samples undergo RNase treatment before RNA extraction
Heat treatment • Variable temperatures: – 37˚C – internal body temperature – 56˚C – low temp / long time pasteurization – 72˚C – high temp / short time pasteurization • 37˚C had little impact on MNV infectivity, but decreased TV PFU/mL by > 3 log after 4 days and no infectious FCV was observed after 48 hours • 56˚C incubation significantly decreased log PFU/mL after 5 minutes for TV and FCV and after 15 minutes for MNV • 72˚C heat significantly decreased PFU/mL > 3 log after 15 minutes for all three viruses
72˚C 1.2 1.2 1 1 0.8 0.8 0.6 TV 0.6 MNV TV + RNase MNV + RNase 0.4 0.4 0.2 0.2 0 0 TV 72C, 0.5 min 72C, 1 min 72C, 2 min MNV 72C, 0.5 min 72C, 1 min 72C, 2 min 1.2 1 0.8 • 72˚C incubation resulted in little 0.6 FCV change in overall RNA levels FCV + RNase 0.4 • RNase treatment resulted in greater 0.2 decreases in RNA for TV and FCV, 0 FCV 72C, 0.5 min 72C, 1 min 72C, 2 min indicating capsid damage
Acidic environment • Since HuNoV and TV must survive the extremely low pH of the stomach to infect the intestine, the effect of pH3 on each virus was studied • pH 3 has little effect on overall RNA levels for all three viruses, but significantly decreases viral titer (PFU/mL) of FCV • TV infectivity was reduced at 37˚C for 2 hours, but the level is still likely infectious • Additional time-points and pH levels (especially pH2 and pH 9 and 10) will be tested
Ethanol • 40 and 70% EtOH appear to affect RNA levels at long timepoints (30 min), but little effect was seen at 15 sec • RNase treatment showed capsid damage to TV at 30 min for 40 and 70% EtOH but little at 15 sec • TV infectivity was affected by 70 and 90% EtOH at 30 min • While 40 and 70% EtOH were effective for MNV, only 70% EtOH for FCV • TV PFU/mL decreases ~ 2 logs with 70% EtOH and no infectious virus was observed with 90% EtOH after 5 minutes • 70 and 90% EtOH appear to greatly affect TV capsid integrity under dried condition
Bleach • Various concentrations of bleach at 5 min contact time were tested – 10% bleach – 5842 ppm free chlorine – 0.5% bleach – 292.125 ppm free chlorine – 0.01% bleach – 5.8425 ppm free chlorine • For all 3 viruses, only 10% bleach appeared to have a significant effect on RNA level • RNase treatment did not appear to have an added effect, so when bleach affects capsid integrity it also affects the RNA • Interestingly, only 10% bleach had a significant impact on TV and FCV, while 0.5% bleach had significant effect on MNV (~ 2 log drop) • All above experiments will be repeated, including treatment with UV, organic solvents and virus survival at different temperatures and in liquid and on dry surfaces
Epochal evolution of GII.4 • New variants of GII.4 appeared every 2-4 years, resulting in major epidemics • Selection by the herd immunity, similar to that of influenza virus • Trade-off for new HBGA binding properties • Strongly selection by HBGAs, while mild antigenic vatiation may occur, the major secretor binding patterns are not changed • A critical issue on virus transmission, epidemiology and disease control and prevention
Evolution of NoVs selected by HBGAs • Two levels of divergent evolution - five genetic lineages (genogroups) - multiple sublineages (genotypes) • Each lineage and sublineage must have traveled hundreds and thousand years • Well adapted with optimal fitness • Running out sequence spaces • Not easily jump from host to host and from one binding pattern to others
GII.4 is one of the earliest sub-lineages after GII NoVs were introduced to humans
The receptor binding interfaces of GII.4 NoVs are highly conserved • GII.4 underwent only minor antigenic variations, natural flocculation • Future studies by continual surveillance are necessary
Acknowledgment Christina Quigley Wen Lei Marissa Choi Dongsheng Zhang Weiming Zhong Jeff Wei Qiang Fan Ming Tan Funding: USDA-NIFA
You can also read